The Journal of veterinary medical science
-
The therapeutic effects of TCV-309, a novel platelet activating factor antagonist, on hemodynamics in endotoxin-induced shock were evaluated. Ten Beagle dogs were used under general anesthesia and artificial ventilation. ⋯ The results showed that the depression of mean aortic pressure, cardiac output, left ventricular stroke work index and urine volume which occurred in endotoxin shock was significantly improved by administration of TCV-309. These results suggested that TCV-309 was a useful therapeutic for the circulatory disturbance in endotoxin shock.
-
The minimum alveolar concentration (MAC) of sevoflurane required to prevent gross purposeful movement in response to electrical stimulation of the oral mucous membranes was determined in horses, and their physical responses to inhalation of this anesthetic were observed. The MAC was 2.31 +/- 0.11%. ⋯ The end tidal sevoflurane concentration (ESC) required to produce recumbency was 2.54 +/- 0.11%. These results suggest that sevoflurane is a clinically useful anesthetic agent in horses.